Literature DB >> 24072616

ceRNA cross-talk in cancer: when ce-bling rivalries go awry.

Florian A Karreth1, Pier Paolo Pandolfi.   

Abstract

UNLABELLED: The cancer transcriptome is characterized by aberrant expression of both protein-coding and noncoding transcripts. Similar to mRNAs, a significant portion of the noncoding transcriptome, including long noncoding RNAs and pseudogenes, harbors microRNA (miRNA)-response elements (MRE). The recent discovery of competitive endogenous RNAs (ceRNA), natural decoys that compete for a common pool of miRNAs, provides a framework to systematically functionalize MRE-harboring noncoding RNAs and integrate them with the protein-coding RNA dimension in complex ceRNA networks. Functional interactions in ceRNA networks aid in coordinating a number of biologic processes and, when perturbed, contribute to disease pathogenesis. In this review, we discuss recent discoveries that implicate natural miRNA decoys in the development of cancer. SIGNIFICANCE: Cross-talk between ceRNAs through shared miRNAs represents a novel layer of gene regulation that plays important roles in the physiology and development of diseases such as cancer. As cross-talk can be predicted on the basis of the overlap of miRNA-binding sites, we are now one step closer to a complete functionalization of the human transcriptome, especially the noncoding space.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24072616      PMCID: PMC3801300          DOI: 10.1158/2159-8290.CD-13-0202

Source DB:  PubMed          Journal:  Cancer Discov        ISSN: 2159-8274            Impact factor:   39.397


  58 in total

Review 1.  A continuum model for tumour suppression.

Authors:  Alice H Berger; Alfred G Knudson; Pier Paolo Pandolfi
Journal:  Nature       Date:  2011-08-10       Impact factor: 49.962

2.  Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs.

Authors:  Yvonne Tay; Lev Kats; Leonardo Salmena; Dror Weiss; Shen Mynn Tan; Ugo Ala; Florian Karreth; Laura Poliseno; Paolo Provero; Ferdinando Di Cunto; Judy Lieberman; Isidore Rigoutsos; Pier Paolo Pandolfi
Journal:  Cell       Date:  2011-10-14       Impact factor: 41.582

3.  In vivo identification of tumor- suppressive PTEN ceRNAs in an oncogenic BRAF-induced mouse model of melanoma.

Authors:  Florian A Karreth; Yvonne Tay; Daniele Perna; Ugo Ala; Shen Mynn Tan; Alistair G Rust; Gina DeNicola; Kaitlyn A Webster; Dror Weiss; Pedro A Perez-Mancera; Michael Krauthammer; Ruth Halaban; Paolo Provero; David J Adams; David A Tuveson; Pier Paolo Pandolfi
Journal:  Cell       Date:  2011-10-14       Impact factor: 41.582

4.  An extensive microRNA-mediated network of RNA-RNA interactions regulates established oncogenic pathways in glioblastoma.

Authors:  Pavel Sumazin; Xuerui Yang; Hua-Sheng Chiu; Wei-Jen Chung; Archana Iyer; David Llobet-Navas; Presha Rajbhandari; Mukesh Bansal; Paolo Guarnieri; Jose Silva; Andrea Califano
Journal:  Cell       Date:  2011-10-14       Impact factor: 41.582

5.  A non-coding transcript of nephronectin promotes osteoblast differentiation by modulating microRNA functions.

Authors:  Shao-Chen Lee; Ling Fang; Chia-Hui Wang; Shireen Kahai; Zhaoqun Deng; Burton B Yang
Journal:  FEBS Lett       Date:  2011-07-23       Impact factor: 4.124

6.  A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language?

Authors:  Leonardo Salmena; Laura Poliseno; Yvonne Tay; Lev Kats; Pier Paolo Pandolfi
Journal:  Cell       Date:  2011-07-28       Impact factor: 41.582

7.  Expression of CD44 3'-untranslated region regulates endogenous microRNA functions in tumorigenesis and angiogenesis.

Authors:  Zina Jeyapalan; Zhaoqun Deng; Tatiana Shatseva; Ling Fang; Chengyan He; Burton B Yang
Journal:  Nucleic Acids Res       Date:  2010-12-10       Impact factor: 16.971

8.  Expression of distinct RNAs from 3' untranslated regions.

Authors:  Tim R Mercer; Dagmar Wilhelm; Marcel E Dinger; Giulia Soldà; Darren J Korbie; Evgeny A Glazov; Vy Truong; Maren Schwenke; Cas Simons; Klaus I Matthaei; Robert Saint; Peter Koopman; John S Mattick
Journal:  Nucleic Acids Res       Date:  2010-11-12       Impact factor: 16.971

9.  A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA.

Authors:  Marcella Cesana; Davide Cacchiarelli; Ivano Legnini; Tiziana Santini; Olga Sthandier; Mauro Chinappi; Anna Tramontano; Irene Bozzoni
Journal:  Cell       Date:  2011-10-14       Impact factor: 41.582

10.  Deletion of PTENP1 pseudogene in human melanoma.

Authors:  Laura Poliseno; Adele Haimovic; Paul J Christos; Eleazar C Vega Y Saenz de Miera; Richard Shapiro; Anna Pavlick; Russell S Berman; Farbod Darvishian; Iman Osman
Journal:  J Invest Dermatol       Date:  2011-08-11       Impact factor: 8.551

View more
  343 in total

Review 1.  Competing endogenous RNA networks and gastric cancer.

Authors:  Lei-Lei Guo; Chun-Hua Song; Peng Wang; Li-Ping Dai; Jian-Ying Zhang; Kai-Juan Wang
Journal:  World J Gastroenterol       Date:  2015-11-07       Impact factor: 5.742

Review 2.  RNA-mediated gene activation.

Authors:  Alan L Jiao; Frank J Slack
Journal:  Epigenetics       Date:  2013-11-01       Impact factor: 4.528

Review 3.  Circular RNAs function as ceRNAs to regulate and control human cancer progression.

Authors:  Yaxian Zhong; Yajun Du; Xue Yang; Yongzhen Mo; Chunmei Fan; Fang Xiong; Daixi Ren; Xin Ye; Chunwei Li; Yumin Wang; Fang Wei; Can Guo; Xu Wu; Xiaoling Li; Yong Li; Guiyuan Li; Zhaoyang Zeng; Wei Xiong
Journal:  Mol Cancer       Date:  2018-04-07       Impact factor: 27.401

Review 4.  Roles of long noncoding RNAs in gastric cancer and their clinical applications.

Authors:  Weiliang Sun; Yunben Yang; Chunjing Xu; Yi Xie; Junming Guo
Journal:  J Cancer Res Clin Oncol       Date:  2016-05-31       Impact factor: 4.553

5.  Long non-coding RNA OIP5-AS1 serves as an oncogene in laryngeal squamous cell carcinoma by regulating miR-204-5p/ZEB1 axis.

Authors:  Hui Wang; Jiantong Qian; Xiaojing Xia; Ben Ye
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2020-02-03       Impact factor: 3.000

6.  The long non-coding RNA NEAT1 regulates epithelial to mesenchymal transition and radioresistance in through miR-204/ZEB1 axis in nasopharyngeal carcinoma.

Authors:  Yaoyong Lu; Tao Li; Ganbao Wei; Liangbo Liu; Qinsheng Chen; Lufei Xu; Kunqiang Zhang; Dehao Zeng; Rongwei Liao
Journal:  Tumour Biol       Date:  2016-03-28

7.  HOTAIR, a long non-coding RNA driver of malignancy whose expression is activated by FOXC1, negatively regulates miRNA-1 in hepatocellular carcinoma.

Authors:  Dong-Na Su; Shi-Pin Wu; Hong-Tao Chen; Jin-Hua He
Journal:  Oncol Lett       Date:  2016-09-13       Impact factor: 2.967

8.  Pseudogenes as Competitive Endogenous RNAs: Testing miRNA Dependency.

Authors:  Xiaonan Xu; Florian A Karreth
Journal:  Methods Mol Biol       Date:  2021

9.  miRNA regulation of Sirtuin-1 expression in human astrocytoma.

Authors:  Sara Giovanna Romeo; Alfredo Conti; Francesca Polito; Chiara Tomasello; Valeria Barresi; Domenico La La Torre; Maria Cucinotta; Flavio Filippo Angileri; Marcello Bartolotta; Rosa Maria Di Giorgio; M'Hammed Aguennouz
Journal:  Oncol Lett       Date:  2016-08-05       Impact factor: 2.967

10.  Upregulation of long non-coding RNA NNT-AS1 promotes osteosarcoma progression by inhibiting the tumor suppressive miR-320a.

Authors:  Changhui Li; Shouyun Zhang; Tongguo Qiu; Yuanji Wang; David M Ricketts; Chao Qi
Journal:  Cancer Biol Ther       Date:  2018-11-29       Impact factor: 4.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.